Gelteq Limited (GELS)
NASDAQ: GELS · Real-Time Price · USD
0.8428
-0.0218 (-2.52%)
Dec 29, 2025, 1:10 PM EST - Market open
Gelteq Employees
As of June 30, 2025, Gelteq had 8 total employees, including 7 full-time and 1 part-time employees. The number of employees did not change compared to the previous year.
Employees
8
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$33,857
Profits / Employee
-$544,602
Market Cap
9.03M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 8 | 0 | - |
| Jun 30, 2024 | 8 | 0 | - |
| Jun 30, 2023 | 8 | 5 | 166.67% |
| Jun 30, 2021 | 3 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
GELS News
- 13 days ago - Gelteq Furthers Asia Presence Through Partnership with Hong Kong Flag Football Program - GlobeNewsWire
- 20 days ago - Gelteq Signs Three Year Sales Agreement with Shenzhen Mana Health Management Co. Strengthening Gelteq's Nutritional Product Expansion into China - GlobeNewsWire
- 24 days ago - Gelteq Preclinical Study Demonstrates Enhanced Oral Delivery of Oil-Soluble and Poorly Soluble Drugs Using Its Gel-Based Platform - GlobeNewsWire
- 27 days ago - Gelteq to Present at Investor Summit Virtual on December 9, 2025 - GlobeNewsWire
- 5 weeks ago - Gelteq Announces Positive Preclinical Results Demonstrating Enhanced Bioavailability Using Its Proprietary Gel-Based Drug Delivery Platform - GlobeNewsWire
- 6 weeks ago - Healthy Extracts Reports Record Q3 2025, with Revenue up 23% - Accesswire
- 6 weeks ago - Nutraceutical Technology Leader, Healthy Extracts, Invited to Present at the Trickle Research Microcap Conference on November 13, 2025 - Accesswire
- 3 months ago - Gelteq Technology Powers U.S. Product Launches of its Nutraceutical Products for Partner - GlobeNewsWire